The following article is Open access

The chemistry and physics of polyacrylamide gel dosimeters: why they do and don't work

Published under licence by IOP Publishing Ltd
, , Citation K B McAuley 2004 J. Phys.: Conf. Ser. 3 29 DOI 10.1088/1742-6596/3/1/005

1742-6596/3/1/29

Abstract

Three factors that prohibit widespread clinical use of polyacrylamide gel (PAG) dosimeters are polymerization after irradiation ceases, formation of additional polymer near the edges of irradiated zones, and monomer toxicity. Polymerization can occur long after irradiation ceases because polymeric radicals cannot diffuse and terminate with other radicals. Small monomer molecules can diffuse toward trapped polymeric radicals and polymerize. Edge enhancement occurs because acrylamide and bisacrylamide diffuse from regions of high concentration (where the radical concentration is low) to adjacent regions where monomer concentration is low and the radical concentration is high. As monomers diffuse into the irradiated zone, they are polymerized by radicals near the edge. Acrylamide is a neurotoxin and suspected carcinogen that can be absorbed through the skin and inhaled, making it an undesirable monomer for polymer gel dosimetry. Less toxic monomers, such as n-vinyl formamide, should give similar dosimetry results, with less concern for safety. When selecting alternative monomers and cross-linkers for polymer gel dosimetry, it would be advantageous to choose larger molecules that diffuse more slowly, resulting in less edge enhancement. Larger molecules should also lead to improved safety, because they are less easily absorbed through the skin and are less easily vaporized and inhaled.

Export citation and abstract BibTeX RIS

Please wait… references are loading.
10.1088/1742-6596/3/1/005